Table 4.
Covariate and tertiles/groups | Male |
Female |
||||||
---|---|---|---|---|---|---|---|---|
Unadjusted analyses |
Adjusted analyses |
Unadjusted analyses |
Adjusted analyses |
|||||
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Age | 0.98 (0.94–1.02) | 0.409 | NA | 1.05 (1.02–1.07) | < 0.001 | 1.04 (1.02–1.06) | < 0.001 | |
Disease duration | 1.01 (0.9–1.13) | 0.802 | NA | 1.02 (0.99–1.06) | 0.119 | NA | ||
Anti-CCP positivity | 1.21 (0.9–1.64) | 0.183 | NA | 1.08 (0.98–1.19) | 0.103 | NA | ||
Current steroid dose | 0.83 (0.65–1.07) | 0.171 | NA | 0.97 (0.9–1.05) | 0.495 | NA | ||
DAS28 | 1.47 (0.89–2.43) | 0.125 | NA | 2.74 (2.16–3.48) | < 0.001 | 2.68 (2.1–3.43) | < 0.001 | |
BMI | 1.11 (0.95–1.29) | 0.169 | NA | 1.04 (0.98–1.1) | 0.195 | NA | ||
Skeletal muscle mass | 1.02 (0.91–1.13) | 0.715 | NA | 0.86 (0.79–0.93) | < 0.001 | 0.87 (0.8–0.96) | 0.006 | |
Body fat mass | 1.11 (1.0–1.18) | 0.042 | NA | 1.02 (0.99–1.05) | 0.094 | NA | ||
Body fat/skeletal muscle ratio | 1.17 (0.65–2.11) | 0.593 | NA | 2.37 (1.22–4.59) | 0.001 | 2.67 (1.29–5.55) | 0.008 |
OR, odds ratio; CI, confidence interval; NA, not applicable; CCP, citrullinated protein antibody; DAS28, disease activity score in 28 joints; BMI, body mass index.